Vestas Wind Systems Confirms Guidance Despite Drop in Orders
The Danish wind-turbine maker said order intake in the second quarter fell 44% to around 2 gigawatts as customers awaited clarity over future wind-energy policy. This was particularly evident in the U.S., Vestas said. The Trump administration has repeatedly criticized wind-energy and has taken steps to halt or delay projects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
28 minutes ago
- Wall Street Journal
America's Stock-Market Dominance Is an Emergency for Europe
The London Stock Exchange overhauled the ceremony for welcoming new companies to its ranks last year, adding confetti cannons, slick videos and cinematic music. It has mostly been used for such events as product launches and anniversaries. So far this year, according to Dealogic, six companies have gone public in the U.K., raising $208 million, the lowest level in three decades of data. It isn't much better across the English Channel, despite surging stock markets. Initial public offerings in continental Europe have nearly halved in value compared with last year. Fundraising in the U.S., meanwhile, has jumped 38% to around $40 billion, while IPOs more than doubled in value in Hong Kong after a fallow patch. Tech stars such as the Swedish 'buy now, pay later' company Klarna and the British chip designer Arm are eschewing local markets to list in New York. And stock-market heavyweights are disappearing, either bought out by American companies or moving their listings stateside, where business is growing faster. Examples are Wise, the British payments company, and the sports-betting company Flutter Entertainment. 'For the Europeans who are responsible for the future, this is a material wake-up call,' said Stéphane Boujnah, chief executive officer of Euronext, which owns seven stock exchanges in the region. Europe doesn't want to 'be just a zone between America and Asia,' he added.
Yahoo
an hour ago
- Yahoo
BMO Capital Lifts PT on Criteo S.A. (CRTO) to $51 From $49, Keeps an Outperform Rating
Criteo S.A. (NASDAQ:CRTO) is one of the top cheap stocks that will go to the moon according to Reddit. On July 31, BMO Capital analyst Brian Pitz raised the firm's price target on Criteo S.A. (NASDAQ:CRTO) to $51 from $49, keeping an Outperform rating on the shares. A graphic designer in front of a computer rendering a cutting edge digital advertisement for the company. The analyst told investors in a research note that Criteo S.A. (NASDAQ:CRTO) reported strong fiscal Q2 results, with contribution ex-TAC exceeding consensus. The firm added that the AI opportunity is increasingly in focus, with the leverage of real-time inventory, pricing, and availability data acting as a durable Retail Media advantage. Criteo S.A. (NASDAQ:CRTO) is a France-based company that specializes in digital performance marketing. Its solution comprises its data assets, the Criteo Engine, its advertiser and publisher platforms, and access to inventory. Criteo Engine delivers advertisements through various marketing formats and channels, including native advertising banners, display advertising banners, and more. It operates in around 90 countries and has more than 30 international offices across the Americas, Europe, and the Asia-Pacific regions. While we acknowledge the potential of XXXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. 登入存取你的投資組合
Yahoo
an hour ago
- Yahoo
BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform
Novo Nordisk A/S (NYSE:NVO) is one of the top cheap stocks that will go to the moon according to Reddit. On August 13, BNP Paribas Exane upgraded Novo Nordisk A/S (NYSE:NVO) to Neutral from Underperform with a $54 price target. An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. The firm told investors that it sees a more balanced risk/reward now that the company's 'reality' is better reflected in the shares. Novo Nordisk A/S (NYSE:NVO) announced results for the January 1 to June 30 period on August 6, reporting an operating profit growth of 25% in Danish kroner and 29% at constant exchange rates (CER) to DKK 72.2 billion. Management also stated that sales in US Operations rose by 16% in Danish kroner (17% at CER), while sales in International Operations grew by 16% in Danish kroner (19% at CER). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products. While we acknowledge the potential of XXXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
